Hikma PHarmaceuticals Plc annual rePort 2013 notes to tHe comPany financialstatements Continued 45.
Due from suBsiDiaries continueD these balances represent loans that carry interest of 2% to 4.8% 2012: 1.5% to 4.8% per annum charged on the outstanding loan balances.
2013 2012 current assets $m $m due from hikma pharma limited Jersey 7 due from hikma farmaceutica portugal 1 1 due from hikma pharma Germany due from hikma uk limited 74 90 due from hikma limited 1 1 due from hikma mena holdings limited 13 14 due from West-Ward pharmaceutical corp. 1 1 due from hikma pharmaceuticals limited Jordan 39 20 others 2 2 131 136 46. financial assets cash and cash equivalents these comprise cash held by the company and short-term bank deposits with an original maturity of three months or less.
the carrying amount of these assets approximates to their fair value.
47. financial liaBilities other payables the Directors consider that the carrying amount of other payables approximates to their fair value.
Due to suBsiDiaries amounts due to subsidiaries of $16 million 2012: $16 million represent non-interest-bearing loans repayable on demand.
49. long-term financial DeBts the company has a seven-year syndicated term loan of $180 million which was entered into on 27 september 2011. the loan has an outstanding balance at year end of $157 million with a fair value of $154 million from which $22 million is due in one year.
quarterly equal repayments of$6 million commenced on 27 march 2013 18 months after the date of the agreement and will continue until the 84th month after the date ofthe agreement with a bullet payment of 30% at the maturity of the loan.
the loan has been used to finance the Promopharm acquisition andthe groups general capital expenditure.
50. financial Policies for risk management anD tHeir oBJectives currency risk currency risks, as defined by ifrs 7, arise on account of financial instruments being denominated in a currency that is not the functional currency and being of a monetary nature.
the following table illustrates financial assets and liabilities for the company in different currencies: liabilities assets 2013 2012 2013 2012 $m $m $m $m british pound 1 2 1 a sensitivity analysis based on a 1% movement in foreign exchange rates has no material impact on the company results and company statement of changes in equity.
further details on how the company manages the currency risk are given in note 29.
Interest rate risk: an interest rate sensitivity analysis assumes an instantaneous 100 basis point change in interest rates in all currencies from their levels at 31 December 2013, with all other variables held constant.
Based on the composition of the company debt and cash portfolio asat31 December 2013, a 1% increase decrease in interest rates would result in an additional interest expense income of $nil being incurred peryear 2012: $2 million.
